LUCEMYRA: payments to doctors
Payments that named LUCEMYRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $935K
- Providers
- 4,656
- Transactions
- 14,214
- Average per transaction
- $66
The per-transaction average — $66 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,656 providers the average total is $201, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $555,453 | 59.4% |
| USWM, LLC | $314,768 | 33.7% |
| US Worldmeds, LLC | $65,162 | 7.0% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $31 | 0.0% |